Osaic Holdings
BLCM

Osaic Holdings’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Osaic Holdings’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,998
Closed -$975 – 7682
2023
Q1 		$975 Buy
2,998
+186
+7% +$172 ﹤0.01% 6968
2022
Q4 		$1.01K Sell
2,812
-100
-3% -$99 ﹤0.01% 6812
2022
Q3 		$2K Buy
2,912
+2,000
+219% +$2.55K ﹤0.01% 6895
2022
Q2 		$1K Sell
912
-50
-5% -$76 ﹤0.01% 7228
2022
Q1 		$8K Hold
962
– – ﹤0.01% 6295
2021
Q4 		$1K Sell
962
-151
-14% -$304 ﹤0.01% 7306
2021
Q3 		$3K Hold
1,113
– – ﹤0.01% 6799
2021
Q2 		$3K Sell
1,113
-131
-11% -$420 ﹤0.01% 6646
2021
Q1 		$4K Buy
1,244
+348
+39% +$1.51K ﹤0.01% 6318
2020
Q4 		$3K Sell
896
-75
-8% -$317 ﹤0.01% 6007
2020
Q3 		$7K Sell
971
-30
-3% -$203 ﹤0.01% 5466
2020
Q2 		$8K Buy
1,001
+46
+5% +$313 ﹤0.01% 5306
2020
Q1 		$3K Buy
+955
New +$10.3K ﹤0.01% 5607

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Osaic Holdings's BLCM Position: Q2 2023 in Review

Osaic Holdings sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 2,998 shares — an estimated $975 sold.

Osaic Holdings first reported a position in BLCM in Q1 2020 and held it in 13 quarters. The position peaked at $8K in Q1 2022. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Osaic Holdings reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Osaic Holdings sold 2,998 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $975.
  • Osaic Holdings first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2020 and held it in 13 quarters.
  • Osaic Holdings's Bellicum Pharmaceuticals, Inc. position peaked at $8K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.